¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Qualitative platelet defects"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® septal defects of heart ÇÑ±Û ½ÉÀåÀÇ Áß°Ý °á¼Õ
¼³¸í   
  ¼±ÃµÀûÀ¸·Î ½ÉÀå ³»ÀÇ ½É¹æ»çÀÌÁß°Ý(interatrial septum)À̳ª ½É½Ç»çÀÌÁß°Ý(interventricular septum)ÀÌ °á¼ÕµÇ¾î Ç÷·ù°¡ Á¤»óÀûÀ¸·Î È帣Áö ¾Ê´Â °æ¿ì. Á¤»óÀûÀΠ°æ¿ì Ç÷·ù´Â Á¤¸Æ¿¡¼­ ¿ì½É¹æÀ¸·Î ¸ð¿© ¿ì½É½ÇÀ» °ÅÄ£µÚ Æó·Î °¡¼­ »ê¼Ò¸¦ °ø±Þ¹Þ°í ´Ù½Ã ¿Þ½É¹æ, ¿Þ½É½ÇÀ» Â÷·Ê·Î °ÅÃÄ ´ëµ¿¸ÆÀ¸·Î °£´Ù. ÇÏÁö¸¸, ÀÌ °æ¿ì´Â Ç÷·ù°¡ ¾Ð·ÂÀÌ ³ôÀº ¿Þ½É¹æÀ̳ª ¿Þ½É½Ç¿¡¼­ ¾Ð·ÂÀÌ ³·Àº ¿ì½É¹æÀ̳ª ¿ì½É½Ç·Î È帣°Ô µÈ´Ù. µû¶ó¼­ µ¿¸ÆÇǿ͠Á¤¸ÆÇǰ¡ ¼¯À̰ԠµÇ°í, È¯Àڴ ȣÈí°ï¶õ, ¼ºÀå¹ßÀ°Àå¾Ö, ½ÉÀâÀ½ µîÀÌ ³ªÅ¸³ª°í, ½ÉÇÑ °æ¿ì Ã»»öÁõÀ¸·Î ¹ßÀüÇϱ⵵ ÇÑ´Ù. Ä¡·á´Â ¼ö¼úÀûÀ¸·Î ÀÌ °á¼ÕºÎÀ§¸¦ ¸·¾Æ ÁÖ¾î¾ß ÇÑ´Ù.
¿µ¹® platelet ÇÑ±Û Ç÷¼ÒÆÇ
¼³¸í   
  °ñ¼öÀÇ °Å´ë ¼¼Æ÷ÀΠ°Å´ëÇÙ¼¼Æ÷ÀÇ ¼¼Æ÷Áú ÀϺΰ¡ ¶³¾îÁ®¼­ ¼øÈ¯ Ç÷¾× Áß¿¡ ÃâÇöÇÑ °ÍÀ¸·Î Á÷°æÀÌ 2~4¥ìmÀÇ ÀÛÀº °ú¸³Ã¼ÀÌ´Ù. Ç÷¼ÒÆÇÀº ¼Õ»óÀ» ÀÔÀº Ç÷°üÀÇ ³ëÃâµÈ °áÇÕ Á¶Á÷¿¡ ºÙ¾î ¿©·¯ ¹°ÁúÀ» ºÐºñÇÏ¿© ÁöÇ÷ ¹× Ç÷¾× ÀÀ°í¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • qualitative
    1. Á¤¼º- 2. Áú
  • qualitative analysis
    Á¤¼ººÐ¼®
  • qualitative percussion
    ÁúÀûŸÁø(¹ý)
  • mean platelet volume
    Æò±ÕÇ÷¼ÒÆÇ¿ëÀû
  • platelet
    Ç÷¼ÒÆÇ
  • platelet activating factor
    Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
  • platelet adhesion
    Ç÷¼ÒÆÇºÎÂø
  • platelet agglutination
    Ç÷¼ÒÆÇÀÀÁý
  • platelet aggregation
    Ç÷¼ÒÆÇÀÀÁý
  • platelet concentrate
    Ç÷¼ÒÆÇ³óÃ๰
  • platelet demarcation membrane
    Ç÷¼ÒÆÇ±¸È¹¸·
  • platelet factor 3
    Ç÷¼ÒÆÇÀÎÀÚ3
  • platelet factor 4
    Ç÷¼ÒÆÇÀÎÀÚ4
  • platelet sequestration
    Ç÷¼ÒÆÇ°Ý¸®
  • platelet-derived growth factor
    Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • qualitative analysis
    Á¤¼ººÐ¼®
  • qualitative
    Á¤¼º-
  • platelet adhesion
    Ç÷¼ÒÆÇºÎÂø
  • platelet aggregation
    Ç÷¼ÒÆÇÀÀÁý
  • platelet-specific antigen
    Ç÷¼ÒÆÇƯÀÌÇ׿ø
  • platelet concentrate
    Ç÷¼ÒÆÇ³óÃ๰
  • platelet function disorder
    Ç÷¼ÒÆÇ±â´ÉÀÌ»ó
  • platelet activating factor
    Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
  • platelet-derived growth factor
    Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
  • platelet
    Ç÷¼ÒÆÇ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • qualitative analysis
    Á¤¼ººÐ¼®
  • qualitative percussion
    ÁúÀûŸÁø¹ý
  • qualitative
    Á¤¼º-
  • qualitative test
    Á¤¼º°Ë»ç
  • platelet adhesion
    Ç÷¼ÒÆÇºÎÂø
  • platelet agglutination
    Ç÷¼ÒÆÇÀÀÁý
  • platelet aggregation
    Ç÷¼ÒÆÇÀÀÁý
  • platelet-specific antigen
    Ç÷¼ÒÆÇƯÀÌÇ׿ø
  • platelet count
    Ç÷¼ÒÆÇ°è»ê
  • platelet function disorder
    Ç÷¼ÒÆÇ±â´ÉÀÌ»ó
  • platelet activating factor
    Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
  • platelet-derived growth factor
    Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
  • mean platelet volume
    Æò±ÕÇ÷¼ÒÆÇ¿ëÀû
  • platelet demarcation membrane
    Ç÷¼ÒÆÇ±¸È¹¸·
  • platelet
    Ç÷¼ÒÆÇ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • qualitative
    Á¤¼º(ïÒàõ)ÀÇ.
  • qualitative analysis
    Á¤¼ººÐ¼®(ïÒàõÝÂà°).
  • qualitative percussion
    ÁúÀûŸÁø¹ý(òõîÜöèòàÛö).{{}}{{{{
  • qualitative test
    Á¤¼º½ÃÇè(ïÒàõãËúÐ).
  • Grey platelet syndrome
    ±×·¹ÀÌÇ÷¼ÒÆÇÁõÈıº
  • MPV => mean platelet volume
    Æò±ÕÇ÷¼ÒÆÇ¿ëÀû
  • PAF =platelet activating factor
    Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ.
  • PAF= platelet activating factor
    Ç÷¼ÒÆÇ Ȱ¼ºÀÎÀÚ.
  • granulocyte-platelet-lymphocyte antigens
    °ú¸³±¸Ç÷¼ÒÆÇ¸²ÇÁ±¸Ç׿ø
  • hellp(hemolysis, elevated liver enzymes, low platelet),heliminths
    À±Ãæ(ëÌõù)
  • hemorrhagic diathesis,defective platelet function
    Ç÷¼ÒÆÇ±â´É°á¼Õ(úìá³÷ùѦÒöÌÀáß)
  • platelet
    Ç÷¼ÒÆÇ(úìá³÷ù).
  • platelet
    Ç÷¼ÒÆÇ(úìá³÷ù)
  • platelet
    Ç÷¼ÒÆÇ
  • platelet activating factor
    Ç÷¼ÒÆÇ Ȱ¼º ÀÎÀÚ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • leukocyte,adherence defects
    À¯Âø°á¼Õ(ë¨ó·ÌÀáß)
  • leukocyte,microbicidal defects
    »ì±Õ·Â °á¼Õ(߯жÕô ÌÀáß)
  • thumbprint defects
    ¹«Áö¹®°á¼ÕÁõ
  • qualitative
    Á¤¼º(ïÒàõ)ÀÇ.
  • qualitative analysis
    Á¤¼ººÐ¼®(ïÒàõÝÂà°).
  • qualitative percussion
    ÁúÀûŸÁø¹ý(òõîÜöèòàÛö).{{}}{{{{
  • qualitative test
    Á¤¼º½ÃÇè(ïÒàõãËúÐ).
  • blood disc =b. platelet
    Ç÷¼ÒÆÇ(Ì´ËÛ̬).
  • blood platelet =thrombocyte
    Ç÷¼ÒÆÇ(úìá³÷ù).
  • direct platelet count
    Á÷Á¢Ç÷¼ÒÆÇ°è»ê(¹ý)(?Ì´ËÛ̬˭Ë×ËÑ).
  • granulocyte-platelet-lymphocyte antigens
    °ú¸³±¸Ç÷¼ÒÆÇ¸²ÇÁ±¸Ç׿ø
  • hellp(hemolysis, elevated liver enzymes, low platelet),heliminths
    À±Ãæ(ëÌõù)
  • hemorrhagic diathesis,defective platelet function
    Ç÷¼ÒÆÇ±â´É°á¼Õ(úìá³÷ùѦÒöÌÀáß)
  • human platelet antigens=HPA
    ÀÎÇ÷¼ÒÆÇÇ׿ø
  • mean platelet volume
    Æò±ÕÇ÷¼ÒÆÇ¿ëÀû
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Thrombocyte [Blood platelet]
    Ç÷¼ÒÆÇ
    [¿¾ ¿ë¾î] Ç÷¼ÒÆÇ
  • Thrombocyte [Blood platelet]
    Ç÷¼ÒÆÇ
    [¿¾ ¿ë¾î] Ç÷Àü¼¼Æ÷
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • qualitative stool examination
    Á¤¼º´ëº¯°Ë»ç
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blood platelet
    Ç÷¼ÒÆÇ(úìá³÷ù)
  • platelet
    Ç÷¼ÒÆÇ(úìá³÷ù)
  • platelet-activating factor
    Ç÷¼ÒÆÇȰ¼º ÀÎÀÚ(úìá³÷ùüÀàõì×í­)
  • platelet cofactor I
    Ç÷¼ÒÆÇ(úìá³÷ù) º¸ÀÎÀÚ (ÜÍì×í­) I
  • platelet cofactor II
    Ç÷¼ÒÆÇ(úìá³÷ù) º¸ÀÎÀÚ(ÜÍì×í­) II
  • platelet-derived growth factor
    Ç÷¼ÒÆÇÀ¯·¡(úìá³÷ùë¦ÕÎ) ¼ºÀåÀÎÀÚ(à÷íþì×í­)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • platelet
    Ç÷¼ÒÆÇ
  • qualitative
    Á¤¼ºÀÇ
  • qualitative test
    Á¤¼º½ÃÇè
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PHAVER pterygia-heart defects-autosomal recessive inheritance-vertebral defects-ear anomalies-radial defect...
qual quality, qualitative
PA panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'...
PAF paroxysmal atrial fibrillation; peroxisomal assembly factor; phosphodiesterase-activating factor; pl...
PC avoirdupois weight [Lat. pondus civile]; packed cells; paper chromatography; paracortex; parent cell...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AVSD Atrio ventricular septal defects
BDMP Birth Defects Monitoring Program
LRD Limb reduction defects
MACDP Metropolitan Atlanta Congenital Defects Program
MLS Microphthalmia with linear skin defects
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • D69.1
    Qualitative platelet defects
    Á¤¼º Ç÷¼ÒÆÇ °áÇÔ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • qualitative platelet defect
    Á¤»ó Ç÷¼ÒÆÇ °áÇÌÁõ, ÁúÀû Ç÷¼ÒÆÇ °áÇÔ
  • specific congenital heart defects
    °³º° º´¼Ò
  • qualitative analysis
    Á¤¼º ºÐ¼®
    È­ÇÐ ºÐ¼®¹ý Áß¿¡¼­ ½Ã·á°¡ ¾î¶² ¼ººÐÀ¸·Î ±¸¼ºµÇ¾î ÀÖ´ÂÁö ¾Ë¾Æ³»±â À§ÇÑ ºÐ¼®¹ýÀÇ ÃÑĪ. ÀϹÝÀûÀ¸·Î Á¤·® ºÐ¼®À» Çϱâ Àü¿¡ Á¤¼º ºÐ¼®À» ÇÏ°Ô µÈ´Ù. ¹°ÁúÀ» ±¸¼ºÇϰí ÀÖ´Â È­ÇÐÁ¾
  • qualitative percussion
    ÁúÀû ŸÁø¹ý
  • disorder of blood platelet
    Ç÷¼ÒÆÇ Àå¾Ö
  • platelet
    Ç÷¼ÒÆÇ
    1. °ñ¼ö¿¡ ÀÖ´Â °ÅÇÙ ¼¼Æ÷ÀÇ ÆÄÆíÀ¸·Î Á÷°æÀÌ 2-4 §­ Á¤µµ·Î ÇÙÀÌ ¾ø´Ù. Ç÷°ü ¼Õ»ó ½Ã Ç÷°ü ¼Õ»ó ºÎÀ§¸¦ ±â°èÀûÀ¸·Î Æä¼âÇϸç, Ç÷¼ÒÆÇ¿¡¼­ À¯¸®µÈ ¹°ÁúÀÌ Ç÷°üÀ» °­ÇÏ°Ô ¼öÃà½ÃÅ´À¸·Î½á ÁöÇ÷ÀÛ¿ëÀ» ÇÑ´Ù. ¶ÇÇÑ Ç÷¾× ÀÀ°í¿¡µµ °ü¿©ÇÑ´Ù. 2. ÀÛÀº ¿øÇüÁú ÆÇ ¸ð¾çÀ̰í, ÇÙÀÌ ¾ø±â ¶§¹®¿¡ ÁøÁ¤ÇÑ ÀǹÌÀÇ ¼¼Æ÷°¡ ¾Æ´Ï´Ù. À̵éÀº °ñ¼ö¿¡ ÀÖ´Â °Å´ë ÇÙ ¼¼Æ÷ÀÇ ¼¼Æ÷Áú Á¶°¢µéÀÌ ¶³¾îÁ®¼­ µÈ °ÍÀ¸·Î ¼øÈ¯ Ç÷¾× ³»¿¡´Â »ö±òÀÌ ¾ø´Ù.
  • platelet aggragating factor
    Ç÷¼ÒÆÇ ÀÀÁý ¿ä¼Ò, Ç÷¼ÒÆÇ ¾ÇÈ­ ÀÎÀÚ, Ç÷¼ÒÆÇ ¾ÇÈ­ ¿äÀÎ
    ¸é¿ª ±Û·ÎºÎ¸° E¿¡ °¨±¤µÈ È£¿°±â±¸¿¡¼­ÀÇ Ç׿ø ¹ÝÀÀ¿¡ ÀÇÇØ Ç÷¾× ³»¿¡ »ý¼ºµÈ ¹°Áú·Î¼­ Ç÷¼ÒÆÇÀ» ÀÀÁý½Ã۸ç, ¿°ÁõÀ» À¯¹ß½ÃŲ´Ù.
  • platelet concentrate
    Ç÷¼ÒÆÇ ³óÃà¾×
  • platelet fector III
    Ç÷¼ÒÆÇ Á¦ »ï ÀÎÀÚ
  • platelet transfusion
    Ç÷¼ÒÆÇ ¼öÇ÷
  • platelet-activating factor
    Ç÷¼ÒÆÇ Ȱ¼º ÀÎÀÚ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
qualitative alteration In electric irritability, a change in which the muscle contracts as readily on application of the anode as on that of the cathode.
(05 Mar 2000)
qualitative analysis Determination of the nature, as opposed to the quantity, of each of the elements composing a substance.
(05 Mar 2000)
qualitative trait <genetics> A feature that can conveniently and effectively be analyzed by sorting into classes either because there is no satisfactory way of measuring it (as with blood groups) or because it falls into natural classes so that the variation among classes far exceeds that within classes (e.g., the phenotypic effects of many enzyme polymorphisms); existence of categories suggests but does not prove the operation of a major, simple, underlying cause.
Synonym: qualitative trait.
(05 Mar 2000)
gastric filling defects <radiology> Malignant tumours, carcinoma, lymphoma, leiomyosarcoma, metastases, benign, leiomyoma, lipoma, neurofibroma, polyp, hyperplastic, adenomatous, hamartomatous, others, bezoar, Nissen fundoplication, ectopic pancreas
(12 Dec 1998)
midline closure defects <radiology> Anencephaly, encephalocele, 70% occipital, 20% parietal or frontal, 10% basal, agenesis of corpus callosum associated with increased alpha-fetoprotein.
(12 Dec 1998)
colour vision defects Mild to severe impairment in the ability to discriminate or differentiate hues. This disorder may be acquired as a result of diseases of the cones or x chromosome-linked where there is an abnormality but not a complete absence of one of the cone pigments.
(12 Dec 1998)
heart defects, congenital Imperfections or malformations of the heart, existing at birth.
(12 Dec 1998)
heart septal defects Defects in the cardiac septa, resulting in abnormal communications between the opposite chambers of the heart.
(12 Dec 1998)
heart septal defects, atrial Defects in the septum between the atria of the heart, due to failure of fusion between either the septum secundum or the septum primum and the endocardial cushions.
(12 Dec 1998)
heart septal defects, ventricular Congenital defects in the septum between the cardiac ventricles, most often due to failure of the bulbar septum to completely close the interventricular foramen.
(12 Dec 1998)
endocardial cushion defects A spectrum of septal defects associated with persistence of the embryonic atrioventricular canal due to incomplete growth and fusion of the endocardial cushion.
(12 Dec 1998)
furcation defects Conditions in which a bifurcation or trifurcation of the molar tooth root becomes denuded as a result of periodontal disease. It may be followed by tooth mobility, temperature sensitivity, pain, and alveolar bone resorption.
(12 Dec 1998)
acquired platelet function defect <haematology> Platelet function can be affected by a number of different disease processes including polycythaemia vera, leukaemia, myelofibrosis, renal failure, multiple myeloma and some medications (for example penicillins, salicylates, phenothiazines).
Disturbed blood clotting can be manifested by: easy bruising, bleeding gums, nosebleeds, abnormal vaginal bleeding, rectal bleeding, skin rash, vomiting blood, coughing up blood or blood in the urine. A measure of bleeding time and coagulation profile will be part of the evaluation.
(29 Dec 1997)
antigens, human platelet Human alloantigens expressed only on platelets, specifically on platelet membrane glycoproteins. These platelet-specific antigens are immunogenic and can result in pathological reactions to transfusion therapy.
(12 Dec 1998)
anti-platelet agents Medications that, like aspirin, reduce the tendency of platelets in the blood to clump and clot.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • zero defects
    ¹«°áÁ¡ (¿îµ¿)
  • qualitative
    ÁúÀÇ
  • qualitative
    ¼ºÁú»óÀÇ;ÁúÀûÀÎ
  • qualitative analysis
    Á¤¼º ºÐ¼®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á